Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis.
Identifieur interne : 006298 ( Main/Exploration ); précédent : 006297; suivant : 006299Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis.
Auteurs : Uma Vanam [Inde] ; Vivek Pandey ; Prince R. Prabhu ; Gajalakshmi Dakshinamurthy ; Maryada Venkata Rami Reddy ; Perumal KalirajSource :
- The American journal of tropical medicine and hygiene [ 1476-1645 ] ; 2009.
Descripteurs français
- KwdFr :
- Animaux, Anticorps antihelminthe (sang), Antigènes d'helminthe (génétique), Antigènes d'helminthe (immunologie), Brugia malayi (génétique), Brugia malayi (immunologie), Brugia malayi (pathogénicité), Filariose lymphatique (), Filariose lymphatique (immunologie), Filariose lymphatique (parasitologie), Gerbillinae, Humains, Mâle, Peroxirédoxines (génétique), Peroxirédoxines (immunologie), Protéines recombinantes (génétique), Protéines recombinantes (immunologie), Résultat thérapeutique, Transglutaminases (génétique), Transglutaminases (immunologie), Vaccins (administration et posologie), Vaccins (génétique), Vaccins (immunologie), Vaccins à ADN (administration et posologie), Vaccins à ADN (génétique), Vaccins à ADN (immunologie).
- MESH :
- administration et posologie : Vaccins, Vaccins à ADN.
- génétique : Antigènes d'helminthe, Brugia malayi, Peroxirédoxines, Protéines recombinantes, Transglutaminases, Vaccins, Vaccins à ADN.
- immunologie : Antigènes d'helminthe, Brugia malayi, Filariose lymphatique, Peroxirédoxines, Protéines recombinantes, Transglutaminases, Vaccins, Vaccins à ADN.
- parasitologie : Filariose lymphatique.
- pathogénicité : Brugia malayi.
- sang : Anticorps antihelminthe.
- Animaux, Filariose lymphatique, Gerbillinae, Humains, Mâle, Résultat thérapeutique.
English descriptors
- KwdEn :
- Animals, Antibodies, Helminth (blood), Antigens, Helminth (genetics), Antigens, Helminth (immunology), Brugia malayi (genetics), Brugia malayi (immunology), Brugia malayi (pathogenicity), Elephantiasis, Filarial (immunology), Elephantiasis, Filarial (parasitology), Elephantiasis, Filarial (prevention & control), Gerbillinae, Humans, Male, Peroxiredoxins (genetics), Peroxiredoxins (immunology), Recombinant Proteins (genetics), Recombinant Proteins (immunology), Transglutaminases (genetics), Transglutaminases (immunology), Treatment Outcome, Vaccines (administration & dosage), Vaccines (genetics), Vaccines (immunology), Vaccines, DNA (administration & dosage), Vaccines, DNA (genetics), Vaccines, DNA (immunology).
- MESH :
- chemical , administration & dosage : Vaccines, Vaccines, DNA.
- chemical , blood : Antibodies, Helminth.
- chemical , genetics : Antigens, Helminth, Peroxiredoxins, Recombinant Proteins, Transglutaminases, Vaccines, Vaccines, DNA.
- chemical , immunology : Antigens, Helminth, Peroxiredoxins, Recombinant Proteins, Transglutaminases, Vaccines, Vaccines, DNA.
- genetics : Brugia malayi.
- immunology : Brugia malayi, Elephantiasis, Filarial.
- parasitology : Elephantiasis, Filarial.
- pathogenicity : Brugia malayi.
- prevention & control : Elephantiasis, Filarial.
- Animals, Gerbillinae, Humans, Male, Treatment Outcome.
Abstract
An attempt was made to study the immunoprophylactic efficacy of recombinant Brugia malayi transglutaminase (BmTGA) as protein vaccine along with two other recombinant proteins, Brugia malayi abundant larval transcript-2 (BmALT-2) and Brugia malayi thioredoxin peroxidase (BmTPX), in single and multiple antigen form for human lymphatic filariasis. Parasite challenge studies in jirds exhibited protection of 30%, 69%, and 43% against BmTGA, BmALT-2, and BmTPX, respectively, in single antigen vaccination mode. The protective efficacy of BmTGA was enhanced significantly (74%) by immunizing the jirds in multiple antigen vaccination mode along with BmTPX, whereas immunizing with the combination of BmTGA and BmALT2 conferred only 47% protection. The same protection profiles were obtained by in vitro antibody-dependent cellular cytotoxicity, using live microfilariae and L3 stage larvae. The immune response was Th2 biased, irrespective of single or multiple vaccinations. The combination of BmTGA and BmTPX seems to be a promising vaccine candidate against lymphatic filariasis.
PubMed: 19190232
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002F88
- to stream PubMed, to step Curation: 002F88
- to stream PubMed, to step Checkpoint: 002F88
- to stream Ncbi, to step Merge: 003197
- to stream Ncbi, to step Curation: 003197
- to stream Ncbi, to step Checkpoint: 003197
- to stream Main, to step Merge: 006374
- to stream Main, to step Curation: 006298
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis.</title><author><name sortKey="Vanam, Uma" sort="Vanam, Uma" uniqKey="Vanam U" first="Uma" last="Vanam">Uma Vanam</name><affiliation wicri:level="1"><nlm:affiliation>Centre for Biotechnology, Anna University, Chennai, India. umavanam@yahoo.co.in</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Centre for Biotechnology, Anna University, Chennai</wicri:regionArea><wicri:noRegion>Chennai</wicri:noRegion></affiliation></author><author><name sortKey="Pandey, Vivek" sort="Pandey, Vivek" uniqKey="Pandey V" first="Vivek" last="Pandey">Vivek Pandey</name></author><author><name sortKey="Prabhu, Prince R" sort="Prabhu, Prince R" uniqKey="Prabhu P" first="Prince R" last="Prabhu">Prince R. Prabhu</name></author><author><name sortKey="Dakshinamurthy, Gajalakshmi" sort="Dakshinamurthy, Gajalakshmi" uniqKey="Dakshinamurthy G" first="Gajalakshmi" last="Dakshinamurthy">Gajalakshmi Dakshinamurthy</name></author><author><name sortKey="Reddy, Maryada Venkata Rami" sort="Reddy, Maryada Venkata Rami" uniqKey="Reddy M" first="Maryada Venkata Rami" last="Reddy">Maryada Venkata Rami Reddy</name></author><author><name sortKey="Kaliraj, Perumal" sort="Kaliraj, Perumal" uniqKey="Kaliraj P" first="Perumal" last="Kaliraj">Perumal Kaliraj</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2009">2009</date><idno type="RBID">pubmed:19190232</idno><idno type="pmid">19190232</idno><idno type="wicri:Area/PubMed/Corpus">002F88</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002F88</idno><idno type="wicri:Area/PubMed/Curation">002F88</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002F88</idno><idno type="wicri:Area/PubMed/Checkpoint">002F88</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002F88</idno><idno type="wicri:Area/Ncbi/Merge">003197</idno><idno type="wicri:Area/Ncbi/Curation">003197</idno><idno type="wicri:Area/Ncbi/Checkpoint">003197</idno><idno type="wicri:Area/Main/Merge">006374</idno><idno type="wicri:Area/Main/Curation">006298</idno><idno type="wicri:Area/Main/Exploration">006298</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis.</title><author><name sortKey="Vanam, Uma" sort="Vanam, Uma" uniqKey="Vanam U" first="Uma" last="Vanam">Uma Vanam</name><affiliation wicri:level="1"><nlm:affiliation>Centre for Biotechnology, Anna University, Chennai, India. umavanam@yahoo.co.in</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Centre for Biotechnology, Anna University, Chennai</wicri:regionArea><wicri:noRegion>Chennai</wicri:noRegion></affiliation></author><author><name sortKey="Pandey, Vivek" sort="Pandey, Vivek" uniqKey="Pandey V" first="Vivek" last="Pandey">Vivek Pandey</name></author><author><name sortKey="Prabhu, Prince R" sort="Prabhu, Prince R" uniqKey="Prabhu P" first="Prince R" last="Prabhu">Prince R. Prabhu</name></author><author><name sortKey="Dakshinamurthy, Gajalakshmi" sort="Dakshinamurthy, Gajalakshmi" uniqKey="Dakshinamurthy G" first="Gajalakshmi" last="Dakshinamurthy">Gajalakshmi Dakshinamurthy</name></author><author><name sortKey="Reddy, Maryada Venkata Rami" sort="Reddy, Maryada Venkata Rami" uniqKey="Reddy M" first="Maryada Venkata Rami" last="Reddy">Maryada Venkata Rami Reddy</name></author><author><name sortKey="Kaliraj, Perumal" sort="Kaliraj, Perumal" uniqKey="Kaliraj P" first="Perumal" last="Kaliraj">Perumal Kaliraj</name></author></analytic><series><title level="j">The American journal of tropical medicine and hygiene</title><idno type="eISSN">1476-1645</idno><imprint><date when="2009" type="published">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Antibodies, Helminth (blood)</term><term>Antigens, Helminth (genetics)</term><term>Antigens, Helminth (immunology)</term><term>Brugia malayi (genetics)</term><term>Brugia malayi (immunology)</term><term>Brugia malayi (pathogenicity)</term><term>Elephantiasis, Filarial (immunology)</term><term>Elephantiasis, Filarial (parasitology)</term><term>Elephantiasis, Filarial (prevention & control)</term><term>Gerbillinae</term><term>Humans</term><term>Male</term><term>Peroxiredoxins (genetics)</term><term>Peroxiredoxins (immunology)</term><term>Recombinant Proteins (genetics)</term><term>Recombinant Proteins (immunology)</term><term>Transglutaminases (genetics)</term><term>Transglutaminases (immunology)</term><term>Treatment Outcome</term><term>Vaccines (administration & dosage)</term><term>Vaccines (genetics)</term><term>Vaccines (immunology)</term><term>Vaccines, DNA (administration & dosage)</term><term>Vaccines, DNA (genetics)</term><term>Vaccines, DNA (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Anticorps antihelminthe (sang)</term><term>Antigènes d'helminthe (génétique)</term><term>Antigènes d'helminthe (immunologie)</term><term>Brugia malayi (génétique)</term><term>Brugia malayi (immunologie)</term><term>Brugia malayi (pathogénicité)</term><term>Filariose lymphatique ()</term><term>Filariose lymphatique (immunologie)</term><term>Filariose lymphatique (parasitologie)</term><term>Gerbillinae</term><term>Humains</term><term>Mâle</term><term>Peroxirédoxines (génétique)</term><term>Peroxirédoxines (immunologie)</term><term>Protéines recombinantes (génétique)</term><term>Protéines recombinantes (immunologie)</term><term>Résultat thérapeutique</term><term>Transglutaminases (génétique)</term><term>Transglutaminases (immunologie)</term><term>Vaccins (administration et posologie)</term><term>Vaccins (génétique)</term><term>Vaccins (immunologie)</term><term>Vaccins à ADN (administration et posologie)</term><term>Vaccins à ADN (génétique)</term><term>Vaccins à ADN (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Vaccines</term><term>Vaccines, DNA</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Helminth</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Antigens, Helminth</term><term>Peroxiredoxins</term><term>Recombinant Proteins</term><term>Transglutaminases</term><term>Vaccines</term><term>Vaccines, DNA</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antigens, Helminth</term><term>Peroxiredoxins</term><term>Recombinant Proteins</term><term>Transglutaminases</term><term>Vaccines</term><term>Vaccines, DNA</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins</term><term>Vaccins à ADN</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Brugia malayi</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Antigènes d'helminthe</term><term>Brugia malayi</term><term>Peroxirédoxines</term><term>Protéines recombinantes</term><term>Transglutaminases</term><term>Vaccins</term><term>Vaccins à ADN</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Antigènes d'helminthe</term><term>Brugia malayi</term><term>Filariose lymphatique</term><term>Peroxirédoxines</term><term>Protéines recombinantes</term><term>Transglutaminases</term><term>Vaccins</term><term>Vaccins à ADN</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Brugia malayi</term><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="parasitologie" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="parasitology" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Brugia malayi</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Brugia malayi</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antihelminthe</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Gerbillinae</term><term>Humans</term><term>Male</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Filariose lymphatique</term><term>Gerbillinae</term><term>Humains</term><term>Mâle</term><term>Résultat thérapeutique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">An attempt was made to study the immunoprophylactic efficacy of recombinant Brugia malayi transglutaminase (BmTGA) as protein vaccine along with two other recombinant proteins, Brugia malayi abundant larval transcript-2 (BmALT-2) and Brugia malayi thioredoxin peroxidase (BmTPX), in single and multiple antigen form for human lymphatic filariasis. Parasite challenge studies in jirds exhibited protection of 30%, 69%, and 43% against BmTGA, BmALT-2, and BmTPX, respectively, in single antigen vaccination mode. The protective efficacy of BmTGA was enhanced significantly (74%) by immunizing the jirds in multiple antigen vaccination mode along with BmTPX, whereas immunizing with the combination of BmTGA and BmALT2 conferred only 47% protection. The same protection profiles were obtained by in vitro antibody-dependent cellular cytotoxicity, using live microfilariae and L3 stage larvae. The immune response was Th2 biased, irrespective of single or multiple vaccinations. The combination of BmTGA and BmTPX seems to be a promising vaccine candidate against lymphatic filariasis.</div></front></TEI><affiliations><list><country><li>Inde</li></country></list><tree><noCountry><name sortKey="Dakshinamurthy, Gajalakshmi" sort="Dakshinamurthy, Gajalakshmi" uniqKey="Dakshinamurthy G" first="Gajalakshmi" last="Dakshinamurthy">Gajalakshmi Dakshinamurthy</name><name sortKey="Kaliraj, Perumal" sort="Kaliraj, Perumal" uniqKey="Kaliraj P" first="Perumal" last="Kaliraj">Perumal Kaliraj</name><name sortKey="Pandey, Vivek" sort="Pandey, Vivek" uniqKey="Pandey V" first="Vivek" last="Pandey">Vivek Pandey</name><name sortKey="Prabhu, Prince R" sort="Prabhu, Prince R" uniqKey="Prabhu P" first="Prince R" last="Prabhu">Prince R. Prabhu</name><name sortKey="Reddy, Maryada Venkata Rami" sort="Reddy, Maryada Venkata Rami" uniqKey="Reddy M" first="Maryada Venkata Rami" last="Reddy">Maryada Venkata Rami Reddy</name></noCountry><country name="Inde"><noRegion><name sortKey="Vanam, Uma" sort="Vanam, Uma" uniqKey="Vanam U" first="Uma" last="Vanam">Uma Vanam</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006298 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006298 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:19190232
|texte= Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:19190232" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |